Atlas Trials

Efficacy of Intracavernosal as add-on Therapy to Sildenafil 100 mg on Demand Compared to Sildenafil 100 mg on Demand for the Treatment of Erectile Dysfunction (ED) Not Sufficiently Responsive to Standard Therapy With Phosphodiesterase Type 5 Inhibitors

Clinical trial NCT05196308 · COMPLETED

Trial details

NCT number
NCT05196308
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Erectile Dysfunction
Start date
2022-03-18
Primary completion
2024-07-23
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.